News

One indicator has correctly forecasted full-year stock performance 84% of the time.

Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged.

The company is aiming to secure the ‘Medical Device Single Audit Program’ certification by this year.

Tesla shares sank Thursday morning after the electric vehicle maker reported fewer deliveries than analysts had expected for the fourth quarter.

The deal promotes the Crypto.com App and Card, as well as launches reward campaigns for DIB customers.

Tutor Perini announced that former president Gary Smalley has taken over as CEO.

VCs and tech executives believe that crypto and fintech are looking up in 2025.